{
    "2021-10-29": [
        [
            {
                "time": "",
                "original_text": "业务全面开花 国金证券斩获 2021 年中国证券业九项大奖",
                "features": {
                    "keywords": [
                        "国金证券",
                        "中国证券业",
                        "九项大奖"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国金证券?博雅生物买入评级：业绩高速增长，定增方案顺利推进",
                "features": {
                    "keywords": [
                        "国金证券",
                        "博雅生物",
                        "买入评级",
                        "业绩高速增长",
                        "定增方案"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国金证券2021年第十三届金融市场研讨会暨金融产品年度策略会成功举办",
                "features": {
                    "keywords": [
                        "国金证券",
                        "金融市场研讨会",
                        "金融产品",
                        "年度策略会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2022-10-26",
                "original_text": "万孚生物：国金证券股份有限公司、太平洋证券股份有限公司等4家机构于10月26日调研我司",
                "features": {
                    "keywords": [
                        "万孚生物",
                        "国金证券",
                        "太平洋证券",
                        "机构调研"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "国金证券股份有限公司",
                "features": {
                    "keywords": [
                        "国金证券"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}